SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001127855-05-000753
Filing Date
2005-11-29
Accepted
2005-11-28 18:41:51
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 SINOVAC BIOTECH LTD. FORM 20-F AMENDMENT #3, 11.21.05 sinovac20f123104.txt 20-F/A 331449
2 SINOVAC BIOTECH LTD. FORM 20-F/A #3, CERTIFICATION 302, CEO sinovacexh31_1.txt EX-31.1 4446
3 SINOVAC BIOTECH LTD. FORM 20-F/A #3, CERTIFICATION 302, CFO sinovacexh31_2.txt EX-31.2 4503
4 SINOVAC BIOTECH LTD. FORM 20-F/A #3, CERTIFICATION 906, CEO sinovacexh32_1.txt EX-32.1 2275
5 SINOVAC BIOTECH LTD. FORM 20-F/A #3, CERTIFICATION 906, CFO sinovacexh32_2.txt EX-32.2 2367
  Complete submission text file 0001127855-05-000753.txt   347105
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F/A | Act: 34 | File No.: 001-32371 | Film No.: 051229488
SIC: 2834 Pharmaceutical Preparations